Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

GU Cancers 2020 | Nivo and ipi: long-term F/U in RCC

Elizabeth Plimack, MD, MS, Fox Chase Cancer Center, Philadelphia, PA, outlines her research top picks from the 2020 ASCO GU meeting. Specifically, Dr Plimack highlights updates on two studies investigating nivolumab (nivo) and ipilimumab (ipi) in the treatment of renal cell carcinoma (RCC) . This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.